Over the past decade, the number of hospital beds in South Korea increased by approximately 6%,
or more than 25,000 beds. More hospitals beds means that the installed base of infusion pumps, and their overall use, will increase. As a result, the number of disposables used with infusion
pumps will increase as well, driving growth in all the IV set segments.
Abstract The full report suite on the South Korean market for infusion therapy devices includes infusion
pumps, intravenous sets (IV sets), needleless connectors, stopcocks for infusion systems and infusion sets designed for blood transfusion (blood transfusion sets).
Scope 2014-2024
Our reports have been used by over 10K customers, including:
Transformational Health team provides critical insights into the Asian specialty generics market with this research service, highlighting growth opportunities, selected countries’ biopharmaceutical environment, and significant R&D, regulatory, and infrastructure reforms influencing its growth. The report examines similarities and contrasts...
Rising prevalence for chronic diseases and growth in the biologics market are expected to drive the overall growth of the pharmaceutical drug delivery market. The global pharmaceutical drug delivery market is projected to reach USD 2,015.3 billion by 2025 from USD 1,430.5 billion in 2020, at a CAGR of 7.1% during the forecast period 2020-2025....
510 pages •
By Roots Analysis Private Ltd.
• May 2020
INTRODUCTION
Chronic diseases, such as diabetes, cardiovascular disorders, neurological disorders, autoimmune disorders and various types of cancer, are known to be the leading causes of death and disability across the world. The clinical conditions associated with these diseases affect patients’ overall quality of life....
248 pages •
By Asia Market Information & Development Company
• May 2020
China’s demand for Drug Delivery System has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption...
This study covers the world outlook for smart syringes across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative...
This study covers the world outlook for needle-free drug delivery devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These...
The global transradial access market is expected to reach US$ 2,961.79 Mn in 2027 from US$ 1,574.97 Mn in 2018. The market is estimated to grow with a CAGR of 7.7% from 2019-2027. The market for transradial access is expected to grow, owing to factors such as rising inclination for interventional procedures using radial artery access, increasing...
The Global Drug Delivery Technologies Market is poised to grow strong during the forecast period 2017 to 2027. Some of the prominent trends that the market is witnessing include growing focus on pediatric and geriatric patients, rising demand for advancement in technologies, increase in the transformation in lifestyle...
Oral, Inhalable, Injectable/Implantable, Transdermal, Ocular, Nasal/Buccal Drug Delivery Technologies, Biologics, Vaccines The Drug Delivery Technologies market is estimated to grow at a CAGR of 8.3% in the first half of the forecast period. The Oral Drug Delivery Technologies submarket held 50% of this market in 2018. How...
The advantages of administering immunotherapeutic injectables subcutaneously is now well accepted and has been more-or-less institutionalized in the drug life cycle development process for non-oncology indications. Antibody drug products indicated for chronic conditions such as autoimmunity are often re-formulated, re-packaged and re-labeled...
Pharmaceutical
Drug Delivery
Ambulatory Care
Drug Development
Injectable Delivery
Biopharmaceutical
Autoimmune Disease
Chronic Disease
Drug Approval
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.